Who
Abraham Bassan
Director
Company insider
Files Form 4 as: Director, Septerna; Director, Rani Therapeutics Holdings; Director, CARGO Therapeutics; Director, LENZ Therapeutics.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 24 Jun 2021
- Last trade
- 26 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 30 Jun 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,600 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,600 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 19 Aug 2025filed 19 Aug 2025 | CARGO Therapeuticsoption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 18 Jun 2025filed 20 Jun 2025 | CARGO Therapeuticsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 17 Jun 2025filed 20 Jun 2025 | SEPN Septernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,623 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | CARGO Therapeuticsoption or derivative | SEC FORM 4 Code A | —23,742 at $0.00 | filing |
| 9 Nov 2023filed 13 Nov 2023 | CARGO Therapeuticsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 19 Jul 2023filed 21 Jul 2023 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 21 Jun 2022filed 22 Jun 2022 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 24 Jun 2021filed 28 Jun 2021 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.